MedPath

Personalized Nutrition Advice for Optimizing Dietary Calcium Intake in MS Patients

Not Applicable
Completed
Conditions
Multiple Sclerosis
Interventions
Procedure: Dietary advice sheet
Procedure: Individual dietary consultations
Registration Number
NCT02664623
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The main objective of this study is to measure effectiveness at 6 months of personalized dietary advice versus dietary counseling via delivery of a standard advice sheet for optimizing dietary calcium intake (assessed by a food survey based on CIQUAL\* data) in MS patients with ambulatory monitoring.

\*CIQUAL Data: Table of nutritional food composition available on the ANSES (National Agency for Sanitary Security of Food, Environment and Labour) website, published by the Observatory of the Nutritional Quality of Foods. This table includes 1,500 sheets of 58 nutritional components. The data is integrated into the software for calculating ingesta (DATAMEAL) at the Nîmes University Hospital.

Detailed Description

The secondary objectives of this study is to compare the two groups in order to:

A- correlate the impact of the recommendations by sheet or consult with disability, cognitive status, fatigue, depression, quality of life of patients with MS.

B- assess the prevalence of diet changes as an alternative therapy for lactose intolerance in the population and to correlate these changes with dietary calcium intake at baseline (assessed by a food survey based on CIQUAL\* data).

C- assess calcium intake of the patients included via the self-administered frequency questionnaire QALCIMUM® on day 0 and 6 months and to compare them with data obtained by the food survey based on data from CIQUAL.

D- correlate calcium intake of the patients with vitamin D levels at inclusion and establish a biological collection of blood samples from the population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
182
Inclusion Criteria
  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • Patient with a confirmed diagnosis of remitting multiple sclerosis
  • Ambulatory patient (EDSS score < 6.5) who has never had a dietary consultation concerning the optimization of calcium intake
Exclusion Criteria
  • The patient is participating in another non-observational study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The subject is not able to complete a self-administered questionnaire
  • Vitamin D deficiency linked to currently active digestive or general diseases
  • Moderate or severe renal impairment (creatinine clearance <60ml / min)
  • Situations accompanied by increased vulnerability to hypercalcemia, eg arrhythmia or known heart disease, treatment with digitalis, subjects with nephrolithiasis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietary advice sheetDietary advice sheetPatients in this arm will receive a dietary advice sheet at the beginning of the study. Intervention: Dietary advice sheet
Dietary advice sheet + consults with dieticianIndividual dietary consultationsIn addition to receiving a dietary advice sheet at the beginning of the study, patients randomized to this arm will have individual consultations with a dietician at inclusion, month 1 and month 3. Intervention: Dietary advice sheet Intervention: Individual dietary consultations
Dietary advice sheet + consults with dieticianDietary advice sheetIn addition to receiving a dietary advice sheet at the beginning of the study, patients randomized to this arm will have individual consultations with a dietician at inclusion, month 1 and month 3. Intervention: Dietary advice sheet Intervention: Individual dietary consultations
Primary Outcome Measures
NameTimeMethod
Calcium intake in mg per dayMonth 6

Evaluation of calcium intake during a consultation with the dietician (CIQUAL data)

Secondary Outcome Measures
NameTimeMethod
QALCIMUM questionnaire (mg/day)Month 6
Paced Auditory Serial Addition TestMonth 6
Expanded Disability Status Scale (EDSS)Month 6
Hospital Anxiety and Depression ScaleMonth 6
EQ-5D questionnaireMonth 6

EQ-5D™ is a standardised instrument for use as a measure of health outcome. (general health scale).

Mini Fatigue Impact ScaleMonth 6
Dietary classificationDay 0

Patient diet classified as: normal; vegetarian, vegetalian; Seignalet; Kousmine; other.

25-hydroxy-vitamin D (D2 + D3) levels (nmol/L)Day 0
25-hydroxy-vitamin D (D2 + D3) plasma levels (nmol/L)Month 6

Trial Locations

Locations (2)

CH d'Alès

🇫🇷

Alès, France

CHRU de Nîmes - Hôpital Universitaire Carémeau

🇫🇷

Nîmes Cedex 09, France

© Copyright 2025. All Rights Reserved by MedPath